ConductScience.org, home

Paper2299679

Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors.

Moolten FL and 1 other. J Natl Cancer Inst, 1990. Cited by 520 papers, by iCite.

Cite this record

ConductScience Library. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. Papers, record 2299679. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2299679

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors.
PubMed
Journal
J Natl Cancer Inst
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
520
iCite
Relative citation ratio, by iCite
13
iCite
Revised in PubMed
2019-05-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Moolten FLF L
2Wells JMJ M

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Neoplasms, ExperimentalMajor topic
Animals
Ganciclovir
Genetic Therapy
Genetic Vectors
Herpes Simplex
Lymphoma, Non-Hodgkin
Male
Mice
Mice, Inbred BALB C
Retroviridae
Sarcoma, Experimental
Thymidine Kinase

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00871702Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed DiseaseBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by113

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 520 citations.

PMIDTitleJournalYearIn PapersSource
40781473Suicide gene therapy targeting ewing sarcoma via an ewing-specific GGAA promoter.Sci Rep2025https://conductscience.org/library/papers/40781473PubMed
40530157Herpes simplex virus-thymidine kinase/ganciclovir suppressed the growth of lung adenocarcinoma cells accompanied by premature senescence.Transl Cancer Res2025https://conductscience.org/library/papers/40530157PubMed
40390814CAR-T Cell Therapy: Managing Side Effects and Overcoming Challenges.Adv Biomed Res2025https://conductscience.org/library/papers/40390814PubMed
37574780Combined cytotoxic and immune-stimulatory gene therapy using Ad-TK and Ad-Flt3L: Translational developments from rodents to glioma patients.Mol Ther2023https://conductscience.org/library/papers/37574780PubMed
37477829Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy.Cell Mol Life Sci2023https://conductscience.org/library/papers/37477829PubMed
36500454Peptide-Based Nanoparticles for αvβ3 Integrin-Targeted DNA Delivery to Cancer and Uterine Leiomyoma Cells.Molecules2022https://conductscience.org/library/papers/36500454PubMed
35163086Polycondensed Peptide Carriers Modified with Cyclic RGD Ligand for Targeted Suicide Gene Delivery to Uterine Fibroid Cells.Int J Mol Sci2022https://conductscience.org/library/papers/35163086PubMed
34401335Cytopathic effects and local immune responses in repeated neoadjuvant HSV-tk + ganciclovir gene therapy for prostate cancer.Asian J Urol2021https://conductscience.org/library/papers/34401335PubMed
33807011Arming Immune Cells for Battle: A Brief Journey through the Advancements of T and NK Cell Immunotherapy.Cancers (Basel)2021https://conductscience.org/library/papers/33807011PubMed
33391429Current Progress in CAR-T Cell Therapy for Hematological Malignancies.J Cancer2021https://conductscience.org/library/papers/33391429PubMed
33374862"Non-Essential" Proteins of HSV-1 with Essential Roles In Vivo: A Comprehensive Review.Viruses2020https://conductscience.org/library/papers/33374862PubMed
33292474Thymidine kinase 1 through the ages: a comprehensive review.Cell Biosci2020https://conductscience.org/library/papers/33292474PubMed
32642680Suicide gene therapy for the treatment of high-grade glioma: past lessons, present trends, and future prospects.Neurooncol Adv2020https://conductscience.org/library/papers/32642680PubMed
32287331Gene therapy in surgery: Part II: Application to septic shock and to organ transplantation.Acta Chir Austriaca1997https://conductscience.org/library/papers/32287331PubMed
31781985Recent progress in the research of suicide gene therapy for malignant glioma.Neurosurg Rev2021https://conductscience.org/library/papers/31781985PubMed
31429760Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity.Mol Cancer2019https://conductscience.org/library/papers/31429760PubMed
31134006Alpha-Herpesvirus Thymidine Kinase Genes Mediate Viral Virulence and Are Potential Therapeutic Targets.Front Microbiol2019https://conductscience.org/library/papers/31134006PubMed
29239327Influence of vascular endothelial growth factor and radiation on gap junctional intercellular communication in glioblastoma multiforme cell lines.Neural Regen Res2017https://conductscience.org/library/papers/29239327PubMed
28148846Tumor-homing cytotoxic human induced neural stem cells for cancer therapy.Sci Transl Med2017https://conductscience.org/library/papers/28148846PubMed
27877531Fabrication of DNA-antibody-apatite composite layers for cell-targeted gene transfer.Sci Technol Adv Mater2012https://conductscience.org/library/papers/27877531PubMed

See all 113 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2299679

GET https://conductscience.org/api/papers/v1/2299679/cited_by?page=2